Amylyx Pharmaceuticals, Inc. AMLX Increase (Decrease) in Other Operating Assets
Increase (Decrease) in Other Operating Assets at other companies
Other financials
Where this comes from
Reported directly by Amylyx Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOtherOperatingAssets.
The official record: Amylyx Pharmaceuticals, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Amylyx Pharmaceuticals, Inc.'s increase (decrease) in other operating assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Amylyx Pharmaceuticals, Inc.'s increase (decrease) in other operating assets?
- Amylyx Pharmaceuticals, Inc. (AMLX) reported increase (decrease) in other operating assets of $2K in Q1 2026.
- How has Amylyx Pharmaceuticals, Inc.'s increase (decrease) in other operating assets changed year-over-year?
- Amylyx Pharmaceuticals, Inc.'s increase (decrease) in other operating assets increased by 115.4% year-over-year, from -$13K to $2K.
- What does increase (decrease) in other operating assets mean?
- This captures the net change in miscellaneous assets that are not classified as loans, securities, or property, plant, and equipment. It often includes items like accrued interest receivables, prepaid expenses, and other short-term operational assets.